US Cellular: ‘Four Free Phones and Four Lines for $90’
What you need to know about this offer.
Ozempic, Wegovy, and Other GLP-1 RA Medications
Multiple class-action lawsuits regarding the marketing of GLP-1 RAs were transferred to be heard together as part of multidistrict litigation (MDL). More information on the MDL is below.
Case Name (Date)
In Re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
24-md-3094, E.D. Penn.
(2024)
Product/Service
Ozempic, Wegovy, Rybelsus, Saxenda, Victoza, Mounjaro, Zepbound, Trulicity and other GLP-1 RA medications
Allegations
Marketing products as weight-loss medications without adequately disclosing that many people stop using them due to their side effects, the medications do not result in meaningful weight loss for up to 15 percent of people, the average weight loss is approximately 10 percent of a person’s body weight, and people need to stay on them to maintain their weight loss
Status
Pending
The Latest
Monetizing Minors: Aneliese German (aka Lisi Shops)
What’s this kidfluencer doing promoting a “youth cream”?
This Secretive Company Built An Empire By Hawking Bad Financial And Health Advice On Facebook
Emily Baker-White, Forbes
Instaflex Advanced
Can this joint supplement back up its stiff promises?
Renewal by Andersen Reported for Making Deceptive Made in USA Claims
MADISON, CONN. July 1, 2025 – Renewal by Andersen, which bills itself as “one of largest replacement window companies in the country,” is deceptively marketing its products as Made in…